New stringent drug patent and marketing rules being negotiated in a Free Trade Agreement (FTA) between the US and Thailand would limit competition and reduce access to affordable medicines in Thailand. This would threaten the future of existing successful Thai HIV/AIDS treatment programmes, which rely on inexpensive generic drugs, and thus deprive thousands of people of effective treatment. Oxfam opposes an FTA with intellectual property rules that exceed the standards agreed at the World Trade Organization.
Published
2006
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.